AviadoBio

AviadoBio's mission is to transform the lives of patients with neurodegenerative diseases by developing and delivering transformative gene therapies for conditions such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company's technology is based on groundbreaking research from King's College London and the UK Dementia Research Institute.